These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular studies of the Oka varicella vaccine. Quinlivan M; Breuer J; Schmid DS Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621 [TBL] [Abstract][Full Text] [Related]
3. Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms. Jin L; Xu S; Maple PAC; Xu W; Brown KE Epidemiol Infect; 2017 Sep; 145(12):2618-2625. PubMed ID: 28748773 [TBL] [Abstract][Full Text] [Related]
4. Molecular and therapeutic aspects of varicella-zoster virus infection. Quinlivan M; Breuer J Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and current approaches to control of varicella-zoster virus infections. Gershon AA; Gershon MD Clin Microbiol Rev; 2013 Oct; 26(4):728-43. PubMed ID: 24092852 [TBL] [Abstract][Full Text] [Related]
6. Molecular studies of Varicella zoster virus. Quinlivan M; Breuer J Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838 [TBL] [Abstract][Full Text] [Related]
10. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany. Sauerbrei A; Wutzler P J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537 [TBL] [Abstract][Full Text] [Related]
12. Evolution of cocirculating varicella-zoster virus genotypes during a chickenpox outbreak in Guinea-Bissau. Depledge DP; Gray ER; Kundu S; Cooray S; Poulsen A; Aaby P; Breuer J J Virol; 2014 Dec; 88(24):13936-46. PubMed ID: 25275123 [TBL] [Abstract][Full Text] [Related]
13. Insights From Studies of the Genetics, Pathogenesis, and Immunogenicity of the Varicella Vaccine. Arvin AM J Infect Dis; 2022 Oct; 226(Suppl 4):S385-S391. PubMed ID: 36265853 [TBL] [Abstract][Full Text] [Related]
14. Live attenuated varicella vaccine. Arvin AM; Gershon AA Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076 [TBL] [Abstract][Full Text] [Related]
15. Nationwide distribution of varicella-zoster virus clades in China. Xu S; Chen M; Zheng H; Wang H; Chen M; Zhou J; Shuang W; Yu P; Ma C; He J; Feng D; Zhen Z; Yan Z; Naiying M; Cui A; Wu Q; Qi M; Li C; Xu X; Xu W BMC Infect Dis; 2016 Oct; 16(1):542. PubMed ID: 27717328 [TBL] [Abstract][Full Text] [Related]
18. Latency and reactivation of varicella zoster virus infections. Dueland AN Scand J Infect Dis Suppl; 1996; 100():46-50. PubMed ID: 9163025 [TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular aspects of the live attenuated Oka varicella vaccine. Quinlivan M; Breuer J Rev Med Virol; 2014 Jul; 24(4):254-73. PubMed ID: 24687808 [TBL] [Abstract][Full Text] [Related]
20. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Breuer J; Whitley R Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]